- Home
- PINC vs HRMY Comparison
PINC vs HRMY Comparison
Compare PINC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINC
- HRMY
- Stock Information
- Founded
- PINC 2013
- HRMY 2017
- Country
- PINC United States
- HRMY United States
- Employees
- PINC N/A
- HRMY N/A
- Industry
- PINC Other Consumer Services
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- PINC Consumer Discretionary
- HRMY Health Care
- Exchange
- PINC Nasdaq
- HRMY Nasdaq
- Market Cap
- PINC 1.9B
- HRMY 2.0B
- IPO Year
- PINC 2013
- HRMY 2020
- Fundamental
- Price
- PINC $22.01
- HRMY $32.16
- Analyst Decision
- PINC Hold
- HRMY Strong Buy
- Analyst Count
- PINC 6
- HRMY 9
- Target Price
- PINC $22.20
- HRMY $54.22
- AVG Volume (30 Days)
- PINC 2.4M
- HRMY 620.8K
- Earning Date
- PINC 08-19-2025
- HRMY 08-05-2025
- Dividend Yield
- PINC 3.82%
- HRMY N/A
- EPS Growth
- PINC N/A
- HRMY 13.13
- EPS
- PINC 0.63
- HRMY 2.62
- Revenue
- PINC $1,260,388,000.00
- HRMY $744,852,000.00
- Revenue This Year
- PINC N/A
- HRMY $20.10
- Revenue Next Year
- PINC N/A
- HRMY $18.01
- P/E Ratio
- PINC $20.19
- HRMY $12.27
- Revenue Growth
- PINC 7.16
- HRMY 20.62
- 52 Week Low
- PINC $17.23
- HRMY $26.47
- 52 Week High
- PINC $23.56
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- PINC 47.12
- HRMY 43.25
- Support Level
- PINC $21.40
- HRMY $31.70
- Resistance Level
- PINC $22.06
- HRMY $33.69
- Average True Range (ATR)
- PINC 0.45
- HRMY 0.89
- MACD
- PINC -0.07
- HRMY -0.10
- Stochastic Oscillator
- PINC 45.86
- HRMY 37.30
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.